Physician‐related barriers |
Skills |
Lack of research on older adults with multimorbidity.26
|
Slightly (5%) |
Very (60%) |
Extremely (15%) |
1 |
Environmental context and resources |
Hesitancy in changing medications that have been prescribed in their current dosage for a long period, or when not the original prescriber.20
|
Low (5%) |
Very (35%) |
Extremely (20%) |
1 |
Intentions |
Easier to maintain the status quo rather than interfere with drug regimens in a stable patient.27
|
Neutral (5%) |
Very (45%) |
Extremely (15%) |
1 |
Professional/social role and identity |
Reluctance to interfere with medications that have been prescribed by a colleague or specialist (ie, hesitation in discontinuing medications prescribed by another physician).21
|
Slightly (5%) |
Very (45%) |
Extremely (15%) |
1 |
Patient‐related Barriers |
Knowledge |
Patients do not understand what medications they are taking.17
|
Slightly (5%) |
Very (50%) |
Extremely (10%) |
1 |
Healthcare System–related Barriers |
Environmental context and resources |
Patients follow up with multiple hospitals and receive medications from multiple providers.22
|
Moderately (10%) |
Very (55%) |
Extremely (35%) |
1 |
Increased specialization in healthcare (ie, focus on subspecialty‐based care instead of overall management).28
|
Slightly (5%) |
Very (50%) |
Extremely (20%) |
1 |
Fragmentation of care, lack of a specific or unified physician to follow up with23
|
Moderately (20%) |
Very (55%) |
Extremely (25%) |
1 |
Lack of coordination or communication between transitions and various levels of care across healthcare settings.21, 29
|
Slightly (5%) |
Very (40%) |
Extremely (20%) |
1 |
Exclusion of multimorbid older adults in clinical trials.21
|
Neutral (20%) |
Very (55%) |
Very (55%) |
1 |
Lack of ownership to assume responsibility for optimizing a specific patient's care plans.24
|
Neutral (5%) |
Very (65%) |
Extremely (25%) |
1 |